Search

Bridget E. Bunner

Examiner (ID: 19030, Phone: (571)272-0881 , Office: P/1647 )

Most Active Art Unit
1647
Art Unit(s)
1644, 1647
Total Applications
1463
Issued Applications
725
Pending Applications
157
Abandoned Applications
602

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1059223 [patent_doc_number] => 06852313 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-08 [patent_title] => 'Method of stimulating growth of melanocyte cells by administering stem cell factor' [patent_app_type] => utility [patent_app_number] => 09/604325 [patent_app_country] => US [patent_app_date] => 2000-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 95 [patent_no_of_words] => 51157 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/852/06852313.pdf [firstpage_image] =>[orig_patent_app_number] => 09604325 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/604325
Method of stimulating growth of melanocyte cells by administering stem cell factor Jun 25, 2000 Issued
09/554317 NEURALIZED PROTEINS, POLYNUCLEOTIDES CODING THE PROTEINS, AND ANTIBODIES RECOGNIZING THE PROTEINS. Jun 19, 2000 Abandoned
09/596562 G-Protein Coupled Receptor, CD97 Jun 18, 2000 Abandoned
09/594938 Generation of hematopoietic cells from multipotent neural stem cells Jun 14, 2000 Abandoned
Array ( [id] => 1027533 [patent_doc_number] => 06881401 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-19 [patent_title] => 'Methods of treatment of immune system related disorders using Neutrokine-alpha' [patent_app_type] => utility [patent_app_number] => 09/589285 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 34 [patent_no_of_words] => 162646 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/881/06881401.pdf [firstpage_image] =>[orig_patent_app_number] => 09589285 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/589285
Methods of treatment of immune system related disorders using Neutrokine-alpha Jun 7, 2000 Issued
Array ( [id] => 7631450 [patent_doc_number] => 06635482 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-21 [patent_title] => 'Monoclonal antibodies to membrane neutrokine-' [patent_app_type] => B1 [patent_app_number] => 09/589286 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 34 [patent_no_of_words] => 168138 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/635/06635482.pdf [firstpage_image] =>[orig_patent_app_number] => 09589286 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/589286
Monoclonal antibodies to membrane neutrokine- Jun 7, 2000 Issued
Array ( [id] => 7976691 [patent_doc_number] => 08071092 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-12-06 [patent_title] => 'Methods of inhibiting B lymphocytes using antibodies to Neutrokine-alpha' [patent_app_type] => utility [patent_app_number] => 09/589288 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 34 [patent_no_of_words] => 162648 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071092.pdf [firstpage_image] =>[orig_patent_app_number] => 09589288 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/589288
Methods of inhibiting B lymphocytes using antibodies to Neutrokine-alpha Jun 7, 2000 Issued
09/587441 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury Jun 4, 2000 Abandoned
09/578298 Secreted alpha-helical protein-2 May 24, 2000 Abandoned
09/571429 HLWAR77_v1, A G-protein coupled receptor May 14, 2000 Abandoned
09/563875 AXOR61, A G-protein coupled receptor May 2, 2000 Abandoned
Array ( [id] => 1284273 [patent_doc_number] => 06638711 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation' [patent_app_type] => B1 [patent_app_number] => 09/560883 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 21839 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638711.pdf [firstpage_image] =>[orig_patent_app_number] => 09560883 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/560883
Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation Apr 27, 2000 Issued
09/553927 Methods for identifying compounds useful for preventing acute clinical vascular events in a subject Apr 20, 2000 Abandoned
Array ( [id] => 1364751 [patent_doc_number] => 06566047 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Method for identifying neurite-growth promoting agents' [patent_app_type] => B1 [patent_app_number] => 09/463259 [patent_app_country] => US [patent_app_date] => 2000-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 23107 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566047.pdf [firstpage_image] =>[orig_patent_app_number] => 09463259 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/463259
Method for identifying neurite-growth promoting agents Apr 17, 2000 Issued
09/547580 Method of diagnosing transmissible spongiform encephalopathies Apr 11, 2000 Abandoned
09/547276 Clasp-2 transmembrane proteins Apr 10, 2000 Abandoned
Array ( [id] => 1528711 [patent_doc_number] => 06479638 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor' [patent_app_type] => B1 [patent_app_number] => 09/546049 [patent_app_country] => US [patent_app_date] => 2000-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46287 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479638.pdf [firstpage_image] =>[orig_patent_app_number] => 09546049 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/546049
Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor Apr 9, 2000 Issued
Array ( [id] => 736751 [patent_doc_number] => 07033784 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-25 [patent_title] => 'Method of producing an erythroid cell which is undifferentiated yet capable of expressing a heterologous protein' [patent_app_type] => utility [patent_app_number] => 10/009231 [patent_app_country] => US [patent_app_date] => 2000-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9825 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/033/07033784.pdf [firstpage_image] =>[orig_patent_app_number] => 10009231 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/009231
Method of producing an erythroid cell which is undifferentiated yet capable of expressing a heterologous protein Apr 4, 2000 Issued
09/542415 Mouse edg5 gene Apr 3, 2000 Abandoned
09/541226 Promoting cell growth by inhibiting enabled proteins or their ligands Apr 2, 2000 Abandoned
Menu